251120 — Bio-FD&C Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for Bio-FD&C Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	8,476	8,640	11,972	15,855	15,592
Cost of Revenue
Gross Profit	5,650	5,639	7,126	10,996	11,029
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Total Operating Expenses	5,579	5,715	8,835	10,975	10,558
Operating Profit	2,898	2,925	3,138	4,881	5,034
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,993	2,881	3,293	5,443	7,152
Provision for Income Taxes
Net Income After Taxes	2,562	2,461	2,908	4,335	5,585
Net Income Before Extraordinary Items
Net Income	2,562	2,461	2,908	4,335	5,585
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	2,562	2,461	2,908	4,335	5,585
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	293	283	393	492	655
Dividends per Share